Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab helped control a child's severe eye disease when other treatments failed.

Minoxidil in breast milk may harm nursing infants.

Dermatologists diagnose and manage melanoma more effectively than general practitioners.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Effective treatments for severe alopecia areata are still lacking.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The document lists various dermatology topics, treatments, and diagnostic methods.

New alopecia treatments aim for better results and fewer side effects.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.